Mupirocin Prophylaxis to Prevent Staphylococcus aureus Infection in Patients Undergoing Dialysis: A Meta-analysis
Open Access
- 15 December 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (12) , 1629-1638
- https://doi.org/10.1086/379715
Abstract
A systematic review of the English-language literature was performed to determine the overall benefit of mupirocin therapy in reducing the rate of StKeywords
This publication has 32 references indexed in Scilit:
- Antimicrobial‐Resistant, Gram‐Positive Bacteria among Patients Undergoing Chronic HemodialysisClinical Infectious Diseases, 2002
- Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfectionsNew England Journal of Medicine, 2002
- National Surveillance of Dialysis‐Associated Diseases in the United States, 2000Seminars in Dialysis, 2002
- MRSA patients: proven methods to treat colonization and infectionJournal of Hospital Infection, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Infectious complications of the hemodialysis accessKidney International, 2001
- Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabeticsThe Annals of Thoracic Surgery, 2001
- Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patientsJournal of Hospital Infection, 1998
- Preventing Staphylococcal Infections by Eradicating Nasal Carriage of Staphylococcus aureus: Proceeding With CautionInfection Control & Hospital Epidemiology, 1996
- Staphylococcus aureus Nasal Carriage in Hemodialysis PatientsArchives of internal medicine (1960), 1989